Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Women’s Health Products Market 2019 Witnessing Four Fold Growth by 2026

Author: Chaitanya Godse
by Chaitanya Godse
Posted: Mar 01, 2019

Women health products provide additional nutrients and minerals to the body to increase immunity for prevention of common health issues. Women’s health is a major concern nowadays, as increasing number of women in the workforce translates to lesser time on maintaining health. This makes their body weak and deficient in nutrition and may lead to health problems and diseases such as osteoporosis, vitamin deficiency and infertility. Good nutrition plays a major role to look after women’s health, along with mood and energy level. It is also essential to maintain hormonal balance and precise body requirements throughout women’s life. According to World Health Organization (WHO), in 2014, around 13.3% of women over 18 years were in fair or poor health condition. Various government initiatives and programs by non-governmental bodies has led to increasing awareness among the populace about women’s health and in turn creates a highly conducive environment for growth of the women’s healthcare products market.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/552

Growing awareness fuels the growth of women’s health products market

Increasing expenditure on developing a robust healthcare infrastructure in turn has led to rapid growth in health awareness among the populace, augmented by counselling and educational programs by hospitals. Various government and private bodies have also taken up the initiative with regards to women’s health through care program, college women campaign program, and food safety for moms to be. According to International Osteoporosis Foundation (IOF) report, by 2050, 42% of women over 50 years will experience osteoporosis fractures due to lack of calcium and phosphate. Postmenopausal osteoporosis accounts for the largest market share. Due to government initiative to spread awareness about the contraception and fertility in the emerging economies such as India and China to restrict the population growth is expected to boost the women healthcare market in the near future. In developed economies, most women have stopped using contraceptive pill due to side effects such as endometriosis, menorrhagia, dysmenorrhea, premenstrual syndrome, alopecia, and hirsutism has increased the use of IUDs and implants. Increasing awareness about alternative methods will fuel market growth.

Developed regions are major growth engines of women healthcare market

The global women’s health products market is segmented into different regions: North America, Latin America Asia Pacific, Europe, Middle East and Africa. North America is leading the women’s health products market due to rapidly increasing aging female population, which leads to various health issues such as postmenopausal osteoporosis and endometriosis. Presence of research facilities and labs which helps North America to lead the market. Europe is the second largest emerging region in this market followed by Asia Pacific supported by rapid development in economy and increase in awareness and healthcare facilities.

Major players to support the growth of women’s health products market

Some popular products in the market are bresol syrup, evecare capsules, lukol tablets, reosto, and hiowna.Major players in the women’s healthcare products market are Allergan Pharmaceuticals, Pfizer Pharmaceuticals, Bayer Healthcare, Merck & Co., Teva Pharmaceutical industries, Lupin Ltd., Novo Nordisk Pharmaceutical, GlaxoSmithKline plc., AstraZeneca, Novartis AG, and Sanofi.

Click To Reading More On Women’s Health Products Market

About Coherent Market Insights:

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at

sales@coherentmarketinsights.com

https://www.coherentmarketinsights.com/phase-xs/

Contact Us:

Mr.Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:sales@coherentmarketinsights.com

About the Author

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Chaitanya Godse

Chaitanya Godse

Member since: Oct 06, 2017
Published articles: 252

Related Articles